Negative Effects of a Nonhost Proteinase Inhibitor of ~19.8 kDa from Madhuca indica Seeds on Developmental Physiology of Helicoverpa armigera (Hübner)

por Jamal, Farrukh, Singh, Dushyant, Pandey, Prabhash K.
Publicado 2014

A Nonhost Peptidase Inhibitor of ~14 kDa from Butea monosperma (Lam.) Taub. Seeds Affects Negatively the Growth and Developmental Physiology of Helicoverpa armigera

por Pandey, Prabhash K., Singh, Dushyant, Singh, Sangram, Khan, M. Y., Jamal, Farrukh
Publicado 2014

Outcome of operable oral cavity cancer and impact of maintenance metronomic chemotherapy: A retrospective study from rural India

por Pandey, Avinash, Desai, A., Ostwal, V., Patil, V., Kulkarni, A., Kulkarni, R., Patil, N., Chaukar, D., Prabhash, K., Banavali, Shripad D.
Publicado 2016

Repeatability and reproducibility study of radiomic features on a phantom and human cohort

por Jha, A. K., Mithun, S., Jaiswar, V., Sherkhane, U. B., Purandare, N. C., Prabhash, K., Rangarajan, V., Dekker, A., Wee, L., Traverso, A.
Publicado 2021

Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung

por Doval, DC, Prabhash, K, Patil, S, Chaturvedi, H, Goswami, C, Vaid, AK, Desai, S, Dutt, S, Veldore, VH, Jambhekar, N, Mehta, A, Hazarika, D, Azam, S, Gawande, S, Gupta, S
Publicado 2015

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

por Choughule, A, Sharma, R, Trivedi, V, Thavamani, A, Noronha, V, Joshi, A, Desai, S, Chandrani, P, Sundaram, P, Utture, S, Jambhekar, N, Gupta, S, Aich, J, Prabhash, K, Dutt, A
Publicado 2014

Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?

por Patil, V., Noronha, V., Joshi, A., Muddu Krishna, Vamshi, Juvekar, S., Pantvaidya, Gauri, Chaturvedi, Pankaj, Chaukar, D., Arya, Supreeta, Patil, Aswari, Bhosale, B., Dongre, A., Dcruz, A. K., Prabhash, K.
Publicado 2013

Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma

por Batra, U, Parikh, PM, Prabhash, K, Tongaonkar, HB, Chibber, P, Dabkara, D, Deshmukh, C, Ghadyalpatil, N, Hingmire, S, Joshi, A, Raghunath, SK, Rajappa, S, Rajendranath, R, Rawal, SK, Singh, Manisha, Singh, R, Somashekhar, SP, Sood, R
Publicado 2016

Drug-sensitive FGFR3 mutations in lung adenocarcinoma

por Chandrani, P., Prabhash, K., Prasad, R., Sethunath, V., Ranjan, M., Iyer, P., Aich, J., Dhamne, H., Iyer, D. N., Upadhyay, P., Mohanty, B., Chandna, P., Kumar, R., Joshi, A., Noronha, V., Patil, V., Ramaswamy, A., Karpe, A., Thorat, R., Chaudhari, P., Ingle, A., Choughule, A., Dutt, A.
Publicado 2017

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

por Kanesvaran, R., Castro, E., Wong, A., Fizazi, K., Chua, M.L.K., Zhu, Y., Malhotra, H., Miura, Y., Lee, J.L., Chong, F.L.T., Pu, Y.-S., Yen, C.-C., Saad, M., Lee, H.J., Kitamura, H., Prabhash, K., Zou, Q., Curigliano, G., Poon, E., Choo, S.P., Peters, S., Lim, E., Yoshino, T., Pentheroudakis, G.
Publicado 2022

Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity

por Iqbal, Farwah, Schlotter, Florian, Becker-Greene, Dakota, Lupieri, Adrien, Goettsch, Claudia, Hutcheson, Joshua D, Rogers, Maximillian A, Itoh, Shinsuke, Halu, Arda, Lee, Lang Ho, Blaser, Mark C, Mlynarchik, Andrew K, Hagita, Sumihiko, Kuraoka, Shiori, Chen, Hao Yu, Engert, James C, Passos, Livia S A, Jha, Prabhash K, Osborn, Eric A, Jaffer, Farouc A, Body, Simon C, Robson, Simon C, Thanassoulis, George, Aikawa, Masanori, Singh, Sasha A, Sonawane, Abhijeet R, Aikawa, Elena
Publicado 2023